Mr. Karl Cahill reports

MOSS INTRODUCES DIET AND VITAMIN REPORTS

Moss Genomics Inc. has launched its diet and vitamin reports, which can be ordered directly to your home through the company's on-line platform.

Up to 80 million genetic variants are analyzed to provide the most insightful information concerning dietary needs and vitamin deficiencies. Moss's diet reports provide information about celiac, alcohol sensitivity, sweet tooth, caffeine-related anxiety, hunger, food allergies, response to carbohydrates, bitter taste sensitivity and lactose intolerance. Moss's reports highlight micronutrient deficiencies and requirements such as riboflavin, MTHFR (folate), vitamin B12, vitamin C, vitamin D and iron. These reports give customers the opportunity to further explore and understand their genetic data. Moss customers can enjoy a comprehensive suite of genetic reports available in the company's on-line shop.

"Moss's goal is to empower customers with the tools to understand their own biology and environmental factors which influence their health. The customer is presented with an action plan to meet their physical and mental health goals," said Karl Cahill, chief executive officer of the company.

"Our new diet and vitamin reports give customers 16 different reports based on their genetic information with up to 80 million genetic variants being analyzed."

Moss has created an on-line health care and technology platform integrating labs, services and products in a shared economy. Moss provides comprehensive and affordable, at-home genetic and microbiome testing paired with personalized wellness reports and offerings to promote total gut, mind and body health. The company's services include health reports, personalized food and nutrition recommendations, and a social media platform that allows customers to form communities based on their specific health needs. The company's current and anticipated products can be found in the shop section of its website.

For further information concerning Moss and its business, please view the company's long form prospectus dated Dec. 13, 2022, and Canadian Securities Exchange listing statement dated Jan. 16, 2023, supporting Moss's listing on the CSE, as well as the company's website. Copies of the prospectus and listing statement are available on the company's SEDAR profile.

About Moss Genomics Inc.

Moss Genomics is an emerging consumer genomics company that offers personalized health, anti-aging and wellness offerings guided by genomic, microbiome and epigenome data. The company intends to eliminate barriers in health care by offering easy-access, at-home, affordable testing paired with easy-to-understand actionable results.

We seek Safe Harbor.